1Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry[J]. Lancet Neurol , 2011,10 ( 7 ) 609-617. 被引量：1
2Holmes LB. The teratogenicity of anticonvulsant drugs.- a J progress report[J]. J Med Genet,2002,39(4):245-247. 被引量：1
3Mueller-Kueppers M. On the problem of fetal damage during pregnancy caused by intake of anticonvulsants. [J]. Acta Paedopsychiatr, 1963,30 .. 401-405. 被引量：1
4Hernandez-Diaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy[J]. Neurology, 2012,78(21) :1692- 1699. 被引量：1
5Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn [J]. Lancet, 1972, 2 (7782).. 839- 843. 被引量：1
6Jentink J, Dolk H, Loane MA, et al. Intrauterine exposure to earbamazepine and specific congenital malformations., sys- tematic review and ease-control study[J]. BMJ, 2010, 341 c6581. 被引量：1
7Vajda FJ, Graham J, Roten A, et al. Teratogenicity of the newer antiepileptic drugs the Australian experience [J]. J Clin Neurosci,2012,19(1) 57 -59. 被引量：1
8Jentink J, Loane MA, Dolk H, et al. Valproie acid mono- therapy in pregnancy and major congenital malformations[J]. N Engl J Med,2010,362(23) :2185-2193. 被引量：1
9Wide K, Winbladh B, Kallen B. Major malformations in in- fants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, popula- tion-based register study[J]. Acta Paediatr, 2004,93 (2) :174 -176. 被引量：1
10Molgaard Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects[J]. JAMA, 2011, 305(19) .- 1996-2002. 被引量：1
二级参考文献20
1Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults : expert opinion, 2005. Epilepsy Behav, 2005, 7 Suppl 1 : S1-64. 被引量：1
2French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I. Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2004, 62: 1252-1260. 被引量：1
3Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia, 1998, 39 : 5-17. 被引量：1
4Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med, 2000, 342: 314-319. 被引量：1
5Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet, 2007, 369 : 1016-1026. 被引量：1
6Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus ahernative monotherapy in patients with partial epilepsy failing on a single drug: a muhicentre, randomized, pragmatic controlled trial. Epilepsy Res, 2003, 57: 1-13. 被引量：1
7Kwan P, Brodie MJ. Epilepsy after the first drug fails : substitution or add-on? Seizure, 2000, 9: 464468. 被引量：1
8Hauser WA. Seizure disorders: the changes with age. Epilepsia, 1992, 33 Suppl 4: $6-14. 被引量：1
9Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet, 1998, 352: 1970-1973. 被引量：1
10Faught E. Monotherapy in adults and elderly persons. Neurology, 2007, 69 (24 Suppl 3 ) : $3-$9. 被引量：1
